Almac has Successful MHRA Inspection at its Clinical Services UK Site
Almac
is pleased to announce the successful completion of an inspection of its Clinical Services UK facility located in Craigavon by the Medicines and Healthcare products Regulatory Agency (MHRA)
The routine inspection which took place over four days, from September 13th-September 16th, was conducted by a MHRA inspector who concluded that the site continues to be compliant with EU Good Manufacturing Practices, with no critical or major failures observed.
Commenting on the inspection Paul O’Connor (Vice President, Quality), said:
“We are extremely pleased with the outcome of our inspection. These successful results are a positive reflection of all the investment Almac has made over the past few years in our facilities and recruitment of the best employees. ”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
